Home > Product Catalog > Life science > Nucleosides > α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-benzoate (9CI)
[CAS No.360772-37-8] A1255462 α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-benzoate (9CI) 97%
Catalog No.
Cas No.:
Molecular Formula:
Molecular Weight:
MDL No:
EINECS:
Order/Inquiry/Tech Support
Telephone: 0086-571-89925085
Order & Inquiry: sales@amadischem.com
Tech Support: tech@amadischem.com
*All chemicals from our company are for laboratory and manufacturing use only.
Product Details [360772-37-8]
Synonyms:
Appearance:
Melting point:
Boiling point:
Flash point:
Storage:
Pubchem ID:
Smiles:
Inchi:
InchiKey:
Safety [360772-37-8]
Pictogram:
Signal word:
UN No.:
Danger Category:
Packing Group:
Hazard statements:
Precautionary statements:
Literatures [360772-37-8]
Sorry, the literature is not available.
Similar of [360772-37-8]
α-L-Talofuranuronamide, 5-O-[3-O-(11-amino-1-oxoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(11-aminoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[3-O-[(decyloxy)carbonyl]-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[3-O-[(decyloxy)carbonyl]-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(11-amino-1-oxoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(11-aminoundecanoate) (ACI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(10-aminodecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(15-amino-1-oxo-4,7,10,13-tetraoxapentadec-1-yl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
Reason:Nucleosides
α-L-Talofuranuronamide, 5-O-[3-O-(15-amino-1-oxo-4,7,10,13-tetraoxapentadec-1-yl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
Reason:Nucleosides
α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI)
Reason:Nucleosides
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-nonanoate (9CI)
Reason:Nucleosides
Description [360772-37-8]
Sorry, the product description is not available.
Browsing history
Competitive price
Fast logistics
Technical support
Stock in hand